Daré Bioscience, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2012 | $-21.0M | $-21.2M | $180.0K | $529.0K |
| FY2013 | $-16.6M | $-16.6M | $7.0K | $622.0K |
| FY2014 | $-19.1M | $-19.3M | $225.0K | $885.0K |
| FY2015 | $-31.9M | $-32.2M | $277.0K | $2.4M |
| FY2016 | $-372.3K | $-907.3K | $535.0K | $9.0K |
| FY2017 | $-2.5M | $-2.5M | $0 | $15.8K |
| FY2018 | $-10.3M | $-10.3M | $11.8K | $139.3K |
| FY2019 | $-13.3M | $-13.3M | $0 | $462.2K |
| FY2020 | $-25.2M | $-25.3M | $17.6K | $742.0K |
| FY2021 | $-28.8M | $-28.8M | $14.5K | $1.6M |
| FY2022 | $-18.1M | $-18.2M | $63.1K | $2.2M |
| FY2023 | $-38.9M | $-39.5M | $629.4K | $2.5M |
| FY2024 | $5.5M | $4.9M | $573.0K | $2.2M |
| FY2025 | $-9.9M | $-10.3M | $385.3K | $1.5M |